Yahoo Web Search

Search results

1. • 

     Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

     Zacks via Yahoo Finance· 5 days ago

     With the end of the first-quarter earnings season, the focus has now shifted to pipeline and...

2. • 

     Biogen (BIIB) Stock Down Despite FDA Nod to Alzheimer's Drug

     Zacks via Yahoo Finance· 11 months ago

     Biogen’s BIIB stock was down on Friday despite FDA’s long-awaited full approval to its and partner...

3. • 

     The Zacks Analyst Blog Highlights Bank of America, AT&T, Lockheed Martin, The Progressive and Biogen

     Zacks via Yahoo Finance· 2 years ago

     For Immediate Release Chicago, IL – November 4, 2022 – Zacks.com announces the list of stocks...

4. • 

     Biotech Stock Roundup: BIIB & BMY's Q3 Earnings, TCDA Down on Study Update

     Zacks via Yahoo Finance· 2 years ago

     Earnings results, along with important regulatory and pipeline updates, continue to keep the biotech...

5. • 

     Biotech Stock Roundup: BIIB's AD Drug Data & REGN, IONS, VRTX's Updates

     Zacks via Yahoo Finance· 2 years ago

     It has been a busy week for the biotech companies, with drug approvals and other regulatory news...

6. • 

     Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer's

     Zacks via Yahoo Finance· 1 year ago

     FDA approves Biogen (BIIB) and Eisai's lecanemab on an accelerated basis. Eisai filed a supplemental...

7. • 

     Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates

     Zacks via Yahoo Finance· 3 months ago

     It has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...

8. • 

     Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?

     Zacks via Yahoo Finance· 1 year ago

     A month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...

9. • Hey Biogen Investors, Don’t Chase BIIB Stock!

     InvestorPlace via Yahoo Finance· 2 years ago

     Reportedly, Biogen (NASDAQ:BIIB) and Japanese pharmaceutical company Eisai (OTCMKTS:ESALY) achieved positive test results for their Alzheimer’s disease treatment. As you might expect, BIIB stock ...

10. • 

      The Zacks Analyst Blog Highlights Biogen, Incyte, Morphic Therapeutic and bluebird bio

      Zacks via Yahoo Finance· 1 year ago

      For Immediate Release Chicago, IL – April 27, 2023 – Zacks.com announces the list of stocks featured...